Renal dose dopamine does not alter the response to beta-adrenergic stimulation by isoproterenol in healthy human volunteers. 1997

D A MacGregor, and R C Prielipp, and C S Black, and D J Kennedy, and R W Browder, and J F Butterworth, and R L Royster
Department of Anesthesia, The Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC 27157-1009, USA.

OBJECTIVE To determine if renal dose dopamine (3 microg/kg/min) alters the heart rate (HR) by itself, or if a dopamine infusion alters the HR response to bolus doses of the beta-adrenergic agonist isoproterenol in healthy human subjects. METHODS Prospective study. METHODS Clinical laboratory of a university-affiliated academic medical center. METHODS A total of 15 healthy nonpregnant women and men aged 21 to 44 years. METHODS Subjects were monitored continuously with bedside ECG, pulse oximetry, and ambulatory ECG recording to measure the maximal HR response to separate injections of 10, 20, and 30 ng/kg of isoproterenol, given before, during, and after the infusion of 3 microg/kg/min of dopamine. RESULTS Dopamine in the absence of isoproterenol did not alter baseline HR significantly (62.7+/-2.2 beats/min without dopamine; 65.4+/-2.2 with dopamine; p=0.15). All three doses of isoproterenol increased HR significantly above baseline, both in the presence and absence of dopamine (p<0.001). Dopamine infusion resulted in a higher HR following isoproterenol only for the 20-ng/kg dose. The incremental increases in HR, defined as the difference between peak HR following isoproterenol and baseline HR, were not increased during dopamine infusion for any of the doses of isoproterenol. Nausea was reported by 5 of the 15 subjects during the dopamine infusion. CONCLUSIONS In healthy human subjects, infusion of 3 microg/kg/min of dopamine does not significantly increase the HR when combined with beta-adrenergic stimulation using isoproterenol, suggesting neither an additive nor antagonistic interaction between the two drugs. While our study did not demonstrate an increase in HR in healthy subjects, the risk of increasing the chronotropic response to beta-adrenergic inotropic medications with "renal dose" dopamine in critically ill patients needs to be investigated. The frequency of nausea during dopamine infusion also may influence consideration of using dopamine to augment splanchnic blood flow and renal function in conscious patients.

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D008297 Male Males
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

D A MacGregor, and R C Prielipp, and C S Black, and D J Kennedy, and R W Browder, and J F Butterworth, and R L Royster
November 1988, Clinical pharmacology and therapeutics,
D A MacGregor, and R C Prielipp, and C S Black, and D J Kennedy, and R W Browder, and J F Butterworth, and R L Royster
January 1996, The Journal of clinical psychiatry,
D A MacGregor, and R C Prielipp, and C S Black, and D J Kennedy, and R W Browder, and J F Butterworth, and R L Royster
January 1971, The Journal of clinical investigation,
D A MacGregor, and R C Prielipp, and C S Black, and D J Kennedy, and R W Browder, and J F Butterworth, and R L Royster
November 2010, Journal of acquired immune deficiency syndromes (1999),
D A MacGregor, and R C Prielipp, and C S Black, and D J Kennedy, and R W Browder, and J F Butterworth, and R L Royster
July 1992, Journal of clinical pharmacology,
D A MacGregor, and R C Prielipp, and C S Black, and D J Kennedy, and R W Browder, and J F Butterworth, and R L Royster
June 1991, British journal of clinical pharmacology,
D A MacGregor, and R C Prielipp, and C S Black, and D J Kennedy, and R W Browder, and J F Butterworth, and R L Royster
January 2012, PloS one,
D A MacGregor, and R C Prielipp, and C S Black, and D J Kennedy, and R W Browder, and J F Butterworth, and R L Royster
March 1987, Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova,
D A MacGregor, and R C Prielipp, and C S Black, and D J Kennedy, and R W Browder, and J F Butterworth, and R L Royster
August 2010, The Journal of physiology,
D A MacGregor, and R C Prielipp, and C S Black, and D J Kennedy, and R W Browder, and J F Butterworth, and R L Royster
April 1983, Brain research,
Copied contents to your clipboard!